The Most Favored Nation Deal: A Band Aid on a Bullet Hole The Trump Administration's recent announcement that nine pharmaceutical companies will lower prices for Medicaid programs has been hailed as a major victory in the fight against high drug costs.
However, a closer look reveals that this deal is more of a stopgap measure than a game changing solution.
While the administration claims that these deals cover 90% of the drugs used by Americans, experts point out that for most people, this announcement won't significantly change their costs.